Video

ASCRS Live: Erin Powers shares latest pipeline news from BVI Medical

Erin Powers, Vice President of Global Marketing and Product Strategy for BVI Medical stopped to talk with Ophthalmology Times© at the 2023 ASCRS meeting in San Diego, California to share the latest news from the company.

Erin Powers, Vice President of Global Marketing and Product Strategy for BVI Medical stopped to talk with Ophthalmology Times© at the 2023 ASCRS meeting in San Diego, California to share the latest news from the company.

Video transcript

Editor’s note: Transcript lightly edited for clarity.

Erin Powers:

Hello, everyone. My name is Erin Powers. I'm the vice president of global marketing and product strategy for BVI Medical. I'm so delighted to be at ASCRS in San Diego, beautiful city, my hometown. and I just wanted to update you with a couple of exciting things from BVI. So, oh my goodness, we just got approval for our FINEVISION in Japan. So we're launching that product. We are super excited. We also just closed enrollment for our FINEVISION study in the US, we are very committed to bringing our portfolio globally and really looking at making sure that we provide options to surgeons to better provide options to their patients. So please come by our booth, you can see that we really have surround sound technologies from our consumables...We've got the Beyeonics One partnership that we're working with lenses here in the US. We're really excited to partner more with surgeons here and globally, and really just give you the freedom to choose. So have a fantastic meeting and we look forward to meeting you soon.

Related Videos
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
(Image credit: Ophthalmology Times) AGS 2025: Two-year data of bio-interventional cyclodialysis with scleral allograft with Leon W. Herndon Jr, MD
(Image credit: Ophthalmology Times) AGS 2025: Aqueous humor outflow improvement after excimer laser trabeculostomy with Clemens Strohmaier, PhD
(Image credit: Ophthalmology Times) AGS 2025: Long-term efficacy and safety of standalone and phaco ELT with Marc Toeteberg-Harms, MD
© 2025 MJH Life Sciences

All rights reserved.